Peer Review History

Original SubmissionApril 3, 2020
Decision Letter - Kwasi Torpey, Editor

PONE-D-20-09587

Prevalence and risk factors of healthcare-associated infection in Ethiopia: a systematic review and meta-analysis

PLOS ONE

Dear Abebaw Alemu Yeshambel,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 30th November 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Professor Kwasi Torpey, MD PhD MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. At this time we ask that you include in your manuscript an explanation for the pooling of prevalence data from case-control studies and cross-sectional studies.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments (if provided):

The manuscript titled " Prevalence of risk factors of health associated infections in Ethiopia: a systematic review and meta-analysis" is an important addition in understanding the factors associated with health associated infections within the Ethiopian context. Though the manuscript makes an important contribution it is not publishable in its current form as a result numerous language errors. The manuscript should be reviewed by a native speaker and copyedited thoroughly.

1. Below are some examples (not exhaustive)

a. Abstract Background: emerging of multidrug resistance microbial infection............. emerging should read emergence

b. Following sentence on survey or surveillance should be revised for clarity

c sentence with varied instead of varying

d. Methods: Addis Ababa university: University must start with a capital letter

e. 14,240 were participated for prevalence estimates - Correct language error. participants?

f. Last paragraph on background : Varieties of studies can read as a number of studies

Study selection

g. Screening of title and abstract: This should be plural

h. Quality Assessment: Disagreement was resolved by interference by third reviewer. Appropriate word could be involvement, assessed etc

plus many more

2. a. Reference #9 : remove CAPS

b. #20 - Check

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Title : Prevalence and risk factors of healthcare-associated infection in Ethiopia: a systematic review and meta-analysis

General Comments

o It will be good express why the research focused only “patients because “Healthcare-associated infection” include acquired infection in the health care set up for patients, healthcare workers, and visitors.

o It would be good to see subgroup analysis and observe the prevalence of HCAI in each ward by observing the I2 , rather than “region, study design, diagnostic method and sample size” this may give good insight for the reader as well as specific decision actions?

Specific comments

� Title:

� Abstract:

1. in the abstract section “Addis Ababa university repository.” It is not a research data base but it is a student’s thesis data base, better to use as unpublished grey literature source rather than consider as a scientific repository site?

2. Is it possible to say “The national prevalence of healthcare-associated infection” for this pooled result because, the exposure of Healthcare workers and patients vary from type of facility and vary ward to ward? Did you get similar population to pool the prevalence of HCAI in Ethiopia, for example it may vary , ICU to ophthalmology and Teaching hospital and district hospital in Ethiopian condition?

� Method:

o Is there any reason “There was no restriction of the study period” for this dynamic scientific world, don’t you consider the implementation of IP programs procedural and guidelines change have impact the prevalence of Health care associated infections in Ethiopia? For example, Infection guideline development since 2004 GC has an impact in Ethiopia to manage IP practices? How do you see this?

o “Not applicable because no primary data were collected. Did the protocol published? , why not ?

� Result:

o Subgroup analysis section: it is good to conduct and observe subgroup analysis?

o For risk factors pooled value what was the measure of effect? Is that OR or RR, , don’t you think papers must be similar?

� Discussion:

o Start the discussion with one summary paragraph.

o In the third paragraph of the discussion section “ The possible reasons for high prevalence in this study might be very low hand hygiene practice by physicians,” it needs a reference? May be should be supported by evidence?

� Strength and limitation

Some of the limitation that I observed in this manuscript

- 1. Only one single language English for the inclusion criteria

- 2. Absence of Grey literature in the pooled result

- 3. Absence of time period for the inclusion criteria?

Reviewer #2: Prevalence and risk factors of healthcare-associated infection in Ethiopia: a systematic review and meta-analysis

This study is supposed to be an important work considering the escalation of healthcare-associated infections globally, however, the major drawback noticed is the lack of the systematic review of the identified studies. There is an obvious lack of information on healthcare-associated infections in the manuscript vis-a viz the different types and how the integration of these was done to culminate into meta-analysis.

Please, see comments in the reviewed submitted attachment.

All the best.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: walelegn worku yallew

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-20-09587_reviewer submission.pdf
Revision 1

Point by a point response letter

Dear Academic Editor (Professor Kwasi Torpey, MD Ph.D. MPH), Reviewer #1, and Reviewer #2

After going through the entire manuscript, you forwarded your constructive comments which we missed to touch. Therefore, we are glad enough to express our sincerest thanks for your constructive editorial comments that could help to improve the novelty of our effort.

Editors general comments

Comment: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Author response: Yes indeed, accessing the PLOS ONE style templates from the given links, our manuscript has been made to meet PLOS ONE's style requirements, including those for file naming. These changes were made to meet PLOS ONE's style requirements and found throughout the revised version of the manuscript.

Comment: 2. At this time we ask that you include in your manuscript an explanation for the pooling of prevalence data from case-control studies and cross-sectional studies.

Author response: Yes Sure! We use case-control and cross-sectional studies together to estimate the pooled effect of the determinants of healthcare-associated infection. But, we did not pool the prevalence from case-control and cross-sectional studies together unless specified. Nonetheless, the authors hadn’t encountered a prevalence report from a case-control study, as depicted in Table 1 the prevalence estimate of a pocket study was not presented under the prevalence column for a case-control study included. Now we include a statement that specifies the purpose of including case-control studies in the methods section under the sub-heading inclusion and exclusion criteria.

Comment: 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

Author response: Thank you. We include captions for supporting information files and update the in-text citations accordingly. You can find the caption at the end of the manuscript file following the figures caption.

Additional Editor Comments (if provided):

Comment: The manuscript titled " Prevalence of risk factors of health-associated infections in Ethiopia: a systematic review and meta-analysis" is an important addition in understanding the factors associated with healthcare-associated infections within the Ethiopian context. The manuscript should be reviewed by a native speaker and copyedited thoroughly.

1. Below are some examples (not exhaustive)

a. Abstract Background: emerging of multidrug resistance microbial infection............. emerging should read emergence

b. Following sentence on survey or surveillance should be revised for clarity

c sentence with varied instead of varying

d. Methods: Addis Ababa university: University must start with a capital letter

e. 14,240 were participated for prevalence estimates - Correct language error. participants?

f. Last paragraph on background : Varieties of studies can read as a number of studies

Study selection

g. Screening of title and abstract: This should be plural

h. Quality Assessment: Disagreement was resolved by interference by third reviewer.

Appropriate word could be involvement, assessed etc

plus many more

2. a. Reference #9 : remove CAPS

b. #20 – Check

Authors’ response: Sure! We have tried our best to address the comments from the reviewers. Moreover, from repeated proof-reading of the manuscript, we found several grammatical errors, interlinings, police titles, punctuation errors, wordings, and spelling errors. Therefore, finding our colleague who has a Master of Arts in English, we have done our best to thoroughly copyedit the manuscript for English language usage. These editorial changes are found throughout the revised version manuscript.

Reviewers' general comments:

Reviewer's Responses to Questions

Comments to the Author

Comment: 1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Authors’ response: The design of our research is systematic review and meta-analysis. Based on the quality and strength level of information, evidence from systematic review and meta-analysis is the strongest. The finding is reported based on PRISMA guidelines and the sample size for the current study is high. ________________________________________

Comment: 2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Authors’ response: Thank you for your appreciation! ________________________________________

Comment: 3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Author response: Thank you indeed!

________________________________________

Comment: 4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Authors’ response: Sure! We have tried our best to address the comments from both reviewers. Moreover, from repeated proof-reading of the manuscript, we found several grammatical errors, interlinings, police titles, punctuation errors, wordings, and spelling errors. Therefore, finding our colleague who has a Master of Arts in English, we have done our best to thoroughly copyedit the manuscript for English language usage. These editorial changes are found throughout the revised version manuscript.________________________________________

Review Comments to the Author

Reviewer #1: Comments

General Comments

Comment: It will be good express why the research focused only “patients because “Healthcare-associated infection” include acquired infection in the health care set up for patients, healthcare workers, and visitors.

Authors’ response: Firstly, the meta-analysis is depending on the original studies report. Secondly, whoever he/she is, once they acquired infection in healthcare settings, he/she is considered and treated as a patient.

Comment: It would be good to see subgroup analysis and observe the prevalence of HCAI in each ward by observing the I-square, rather than “region, study design, diagnostic method and sample size” this may give good insight for the reader as well as specific decision actions?

Authors’ response: Yes sure! As per your comment, we do a subgroup analysis based on ward type and include in the revised version of the manuscript, and we found important findings indicating the highest (25.8%) prevalence of HCAI in the intensive care unit (ICU) and pediatrics ward (24.16%). The revision is included in Figure 4 in the results section. You can appreciate the result in the track change version of the manuscript.

Specific comments

Comment: 1. in the abstract section “Addis Ababa university repository.” It is not a research data base but it is a student’s thesis data base, better to use as unpublished grey literature source rather than consider as a scientific repository site?

Authors’ response: Thank you. In fact, Addis Ababa University’s online research repository is not considered as a database as PubMed and other databases. Unpublished works of its own students’ research are deposited to the University online repository. So, we correct the statement as per your comment you can find it as track change on the revised document in the abstract and methods section.

Comment: 2. Is it possible to say “The national prevalence of healthcare-associated infection” for this pooled result because, the exposure of Healthcare workers and patients vary from type of facility and vary ward to ward? Did you get similar population to pool the prevalence of HCAI in Ethiopia, for example it may vary, ICU to ophthalmology and Teaching hospital and district hospital in Ethiopian condition?

Authors’ response: One of the reasons to do systematic review and meta-analysis is the absence of pooled evidence for a country. Different fragmented studies found in different areas could not represent the national level. However, pooling these primary studies could represent the national level. By considering its strength and limitation, the current meta-analysis could be reported as being national prevalence because no data and/or other meta-analysis studies at the national level were published before ours. Besides, as per your comment subgroup analysis is done by ward type and the result is incorporated in the results section under subheading subgroup analysis as Figure 4.

Regarding variations from hospital to hospital, we have found the studies were done at referral and above level hospitals so we were unable to compare the varaiations across district and referral hospitals.

� Method:

Comment: Is there any reason “There was no restriction of the study period” for this dynamic scientific world, don’t you consider the implementation of IP programs procedural and guidelines change have impact the prevalence of Health care associated infections in Ethiopia? For example, Infection guideline development since 2004 GC has an impact in Ethiopia to manage IP practices? How do you see this?

Authors’ response: Usually, the year of publication could not be limited in case of systematic review and meta-analysis. It is known that, the variation of reports between studies conducted at different time periods and across geographical locations. There may be different updates throughout a different time period. There may be an impact due to the involvement of guidelines, policy change, human resources increment, or else. With the presence of such kinds, it is recommended to pool all the available studies to have pooled data. And, though it is not statistically significant the trend analysis showed an increase in the trend of HCAI in Ethiopia as incorporated in the original manuscript in Figure 6.

Comment: “Not applicable because no primary data were collected. Did the protocol published? , why not ?

Author response: Thank you indeed! We include the above statement under ethics approval and consent to participate section of the manuscript in the methods section because no primary data is collected from patients. However, currently, the protocol is registered in the PROSPERO database with a registration number CRD4202016676, and available online:https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020166761

Result:

Comment: Subgroup analysis section: it is good to conduct and observe subgroup analysis?

Author response: Thank you. Yes, Sure! As per your comment, we add the subgroup analysis based on the ward type. You can see Figure 4 in the revised version of the manuscript at the results section under the subheading subgroup analysis.

Comment: For risk factors pooled value what was the measure of effect? Is that OR or RR, don’t you think papers must be similar?

Authors’ response: For this review, we found only 3 studies with cohort study design, and the other is done through a cross-sectional study design. Of these, only one study’s RR pooled with OR. We may combine anything that's trying to estimate the same thing if we have the estimate and standard error, using the inverse-variance method. The question is whether it makes sense to pool them. We may have RR and OR, then assuming the OR is a good approximation to the RR in our case. Thus, we theoretically combine them. Moreover, when the outcomes are rare, or in conducting a nested case-control study then these are approximately equal and can readily be combined. Some researchers decide these are similar enough to combine; others do not. The judgment of the meta-analyst in the context of the aims of the meta-analysis will be required to make such decisions on a case by case basis. OR, RR and HR are all measures of relative risks. Thus, combining OR & RR is sometimes acceptable

� Discussion:

Comment: Start the discussion with one summary paragraph.

Authors’ response: Thank you and we do it now. The changes made could be appreciated in the first paragraph of the discussion section.

Comment: In the third paragraph of the discussion section “The possible reasons for high prevalence in this study might be very low hand hygiene practice by physicians,” it needs a reference? May be should be supported by evidence?

Authors’ response: It is now supported by evidence and updates as per your comment.

Strength and limitation

Comment: Some of the limitation that I observed in this manuscript

- 1. Only one single language English for the inclusion criteria

- 2. Absence of Grey literature in the pooled result

- 3. Absence of time period for the inclusion criteria?

Authors’ response: Thank you! With due respect, we consider these as limitations too. It can be depicted in the strength and limitations section of the revised manuscript in track changes.

Reviewer #2: Comments

Comment: This study is supposed to be an important work considering the escalation of healthcare-associated infections globally, however, the major drawback noticed is the lack of the systematic review of the identified studies. There is an obvious lack of information on healthcare-associated infections in the manuscript vis-a viz the different types and how the integration of these was done to culminate into meta-analysis.

Author response: Thank you. Now all the comments are revised as per the comment.

Specific comments by reviewer #2 taken from the attachment

Comment: Editorial comments throughout the document

Author response: Yes Sure! From repeated proof-reading of the manuscript, we found several grammatical errors, interlinings, police titles, punctuation errors, wordings, and spelling errors. Therefore, finding our colleague who has a Master of Arts in English, we have done our best to thoroughly copyedit the manuscript for English language usage. These editorial changes are found throughout the revised version manuscript.

Background section

Comment: In the background section “Please endeavor to select references that are archived such as that from the World Health Organisation, US Centres for Disease Control and Prevention, etc. Not internet materials for HCAI”

Author response: Yes indeed! We have revised as per your comment, and we use the definitions used by CDC. The changes made could be seen in the introduction section.

Comment: “There is a published document by WHO. Please cite that in the stead. See number 10 citation”

Author response: Thank you indeed. The citation is revised as per the comment given. The revision made is available in the introduction section as track change.

Results section

Comment: The number of pocket studies included were 19 but written as 18

Author response: Thank you for raising this issue. Yes, the total number of studies included for meta-analysis was 19, but the total number of studies used to estimate the prevalence was 18. Nevertheless, the 19th study was case-control which we use it for determinant estimation. So, dear reviewer #2, the discrepancy in the number of studies was due to this scenario. Now, the number of articles included is revised accordingly. You can find the revisions made in the abstract section and the results section as track changes.

Comment. In the results section at subheading risk factors of HCAI, you recommend the risk factors to be presented in the table. “This is better presented as a table where all denominators are known before statistical analysis done on it”

Author response: Yes sure! The revision is made according to your comment and included in Table 3 in the revised version of the manuscript. The changes can be depicted in the results section under sub-heading Determents of healthcare-associated infection.

Decision Letter - Kwasi Torpey, Editor

Healthcare -associated infection and its determinants in Ethiopia: A systematic review and meta-analysis

PONE-D-20-09587R1

Dear Mr Abebew Alemu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Professor Kwasi Torpey, MD PhD MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Comments addressed. There are still a few language corrections needed. Final copyediting will be helpful

Reviewers' comments:

Formally Accepted
Acceptance Letter - Kwasi Torpey, Editor

PONE-D-20-09587R1

Healthcare-associated infection and its determinants in Ethiopia: A systematic review and meta-analysis

Dear Dr. Alemu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Kwasi Torpey

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .